BMP2 and congenital bilateral aplasia of vas deferens from CFTR mutation: In conclusion, miR-664a-3p regulates osteogenic differentiation in AVICs through negative regulation of BMP2, highlighting that miR-664a-3p may be a potential therapeutic target for CAVD.